Clinical trial
Impact of Combined Azithromycin and Ivermectin Mass Drug Administration for Yaws and Scabies - Impact on Impetigo and Skin Microbiology
NCT02775617 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Combined Azithromycin and Ivermectin Mass Drug Administration for Yaws and Scabies - Impact on Impetigo and Skin Microbiology
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- February 5, 2018
- Enrollment
- 1,291 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.